0001209191-18-020353.txt : 20180316
0001209191-18-020353.hdr.sgml : 20180316
20180316181215
ACCESSION NUMBER: 0001209191-18-020353
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20180316
DATE AS OF CHANGE: 20180316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howton David T
CENTRAL INDEX KEY: 0001529297
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 18696963
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-15
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001529297
Howton David T
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
SVP, General Counsel
Common Stock
2018-03-15
4
M
0
23
13.71
A
29321
D
Common Stock
2018-03-15
4
F
0
3
81.22
D
29318
D
Common Stock
2018-03-15
4
M
0
403
13.90
A
29721
D
Common Stock
2018-03-15
4
F
0
68
81.22
D
29653
D
Common Stock
2018-03-15
4
M
0
2074
23.85
A
31727
D
Common Stock
2018-03-15
4
F
0
609
81.22
D
31118
D
Stock option (right to buy)
13.71
2018-03-15
4
M
0
23
0.00
D
2017-02-28
2026-02-28
Common Stock
23
70
D
Stock option (right to buy)
13.90
2018-03-15
4
M
0
403
0.00
D
2016-02-27
2025-02-27
Common Stock
403
5590
D
Stock option (right to buy)
23.85
2018-03-15
4
M
0
2074
0.00
D
2013-11-05
2022-11-05
Common Stock
2074
13018
D
The Reporting Person delivered already-owned shares of Common Stock in payment of the option exercise price. Such an "option swap" enables the exercise and holding of shares of Common Stock by the Reporting Person.
/s/ David Tyronne Howton
2018-03-16